These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34660259)

  • 21. IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism.
    Pu J; Wang J; Qin Z; Wang A; Zhang Y; Wu X; Wu Y; Li W; Xu Z; Lu Y; Tang Q; Wei H
    Front Oncol; 2020; 10():578816. PubMed ID: 33224879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.
    Ji Y; Zhao Q; Feng W; Peng Y; Hu B; Chen Q
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
    Zhong X; Lü M; Wan J; Zhou T; Qin B
    Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
    Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
    Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3-Modulated
    Chen M; Tian B; Hu G; Guo Y
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10.
    Cai J; Cui Z; Zhou J; Zhang B; Lu R; Ding Y; Hu H
    Cancer Cell Int; 2022 Dec; 22(1):385. PubMed ID: 36476503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. m
    Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
    Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of a Novel 2-LncRNAs Signature Associated with m6A Regulation in Colorectal Cancer.
    Wang K; Zhao B; Liang Y; Ma B
    J Cancer; 2022; 13(1):21-33. PubMed ID: 34976168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL3 promotes colorectal cancer metastasis by stabilizing PLAU mRNA in an m6A-dependent manner.
    Yu T; Liu J; Wang Y; Chen W; Liu Z; Zhu L; Zhu W
    Biochem Biophys Res Commun; 2022 Jul; 614():9-16. PubMed ID: 35567945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
    Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
    Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
    Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
    Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.
    Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M
    J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
    Ma XX; Cao ZG; Zhao SL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing.
    Zhang L; Zhao X; Wang J; Jin Y; Gong M; Ye Y; Li P
    Cell Death Discov; 2022 Feb; 8(1):80. PubMed ID: 35210391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H3K27 acetylation-induced lncRNA EIF3J-AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR-3163/YAP1 axis.
    Liu D; Zhang H; Cong J; Cui M; Ma M; Zhang F; Sun H; Chen C
    J Cell Biochem; 2020 Feb; 121(2):1923-1933. PubMed ID: 31709617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A-dependent manner.
    Zhu W; Si Y; Xu J; Lin Y; Wang JZ; Cao M; Sun S; Ding Q; Zhu L; Wei JF
    J Cell Mol Med; 2020 Mar; 24(6):3521-3533. PubMed ID: 32039568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.